Diclofenac Extended-Release Tablets and Moxetumomab pasudotox
Determining the interaction of Diclofenac Extended-Release Tablets and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: diclofenac
Brand name: Cambia, Cataflam, Voltaren-XR, Zipsor, Zorvolex, Voltaren, Dyloject, also Cambia
Synonyms: Diclofenac, Diclofenac (Systemic)
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Diclofenac Extended-Release Tablets-Moxetumomab Pasudotox-tdfk
- Diclofenac Extended-Release Tablets-Moxetumomab pasudotox-tdfk Intravenous
- Diclofenac Extended-Release Tablets-Moxifloxacin
- Diclofenac Extended-Release Tablets-Moxifloxacin (Systemic)
- Diclofenac Extended-Release Tablets-Moxifloxacin Hydrochloride
- Diclofenac Extended-Release Tablets-Moxifloxacin Injection
- Moxetumomab pasudotox-Diclofenac Gel
- Moxetumomab pasudotox-Diclofenac Gel (1%)
- Moxetumomab pasudotox-Diclofenac Gel (3%)
- Moxetumomab pasudotox-Diclofenac Immediate-Release Tablets
- Moxetumomab pasudotox-Diclofenac Injection
- Moxetumomab pasudotox-Diclofenac Intravenous